Ranibizumab in treating age-related macular degeneration
Conclusions1. Monthly treatment with ranibizumab has a substantial inhibitory effect on the course of disease compared to photodynamic therapy or sham injection in patients with neovascular age-related macular degeneration - in followup ≤2 years.2. Monthly treatment improves vision to a substantiall...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Stockholm
Swedish Council on Health Technology Assessment (SBU)
May 21, 2008, 2008
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references